Previous 10 | Next 10 |
2024-05-18 02:35:00 ET Danish pharmaceutical company Novo Nordisk (NYSE: NVO) has established itself as one of the top healthcare stocks in the world with a market cap hovering around $600 billion. Long-term investors earned fantastic returns; in just five years, the share prices of...
2024-05-16 13:37:18 ET More on Viking Therapeutics What Makes Viking Therapeutics An Attractive Takeover Target Or Big Pharma Partner Viking Therapeutics: The Metabolic Masterpiece Primed To Be Acquired Viking Therapeutics, Inc. (VKTX) Q1 2024 Earnings Call Transcrip...
2024-05-16 09:25:33 ET More on Novo Nordisk The FTC Cracks Down On Novo Nordisk's Ozempic Novo Nordisk A/S 2024 Q1 - Results - Earnings Call Presentation Novo Nordisk A/S (NVO) Q1 2024 Earnings Call Transcript Novo Nordisk owner to acquire major stake in Aust...
2024-05-16 06:48:39 ET More on Roche Roche: Value Remains Despite Covid-19 Revenue Growth Loss Roche Holding AG (RHHBY) Q1 2024 Sales/Trading Statement Call Transcript Q1 2024 Sales/ Trading Statement Call J&J, Roche, AstraZeneca poised to have highest or...
2024-05-15 10:37:00 ET It's a good bet that, five years ago, the average American investor would not have been familiar with Novo Nordisk (NYSE: NVO) . That's because the Denmark-based company had not yet won U.S. Food and Drug Administration (FDA) approval for its star drug, weight...
2024-05-15 09:34:32 ET More on Danaher, Novo Nordis, etc. Danaher Corporation (DHR) Presents at BofA Securities 2024 Health Care Conference Call Transcript The FTC Cracks Down On Novo Nordisk's Ozempic Novo Nordisk A/S 2024 Q1 - Results - Earnings Call Presentation ...
2024-05-15 08:45:36 ET Summary Pfizer has been a losing investment for several years, but stronger trading momentum is starting to appear. An easily covered and safety-minded 6% dividend yield is very attractive today. Undervaluation arguments to own shares also exist. PFE sto...
2024-05-15 06:45:00 ET Ozempic, Ozempic, Ozempic. As we all know, Novo Nordisk 's (NYSE: NVO) highly successful drug for type 2 diabetes is grabbing headlines, shrinking waistlines and enriching investors. And thanks to a big investment in a new development partnership, there co...
2024-05-14 14:42:53 ET More on Novo Nordisk The FTC Cracks Down On Novo Nordisk's Ozempic Novo Nordisk A/S 2024 Q1 - Results - Earnings Call Presentation Novo Nordisk A/S (NVO) Q1 2024 Earnings Call Transcript Novo Nordisk: Patients on Wegovy maintain weight ...
2024-05-14 06:59:46 ET Summary Patients on Novo Nordisk's obesity drug Wegovy maintained an average of 10% weight loss over four years. Walmart reportedly plans to lay off corporate jobs and relocate remote workers to central hubs. Uber is acquiring Delivery Hero's foodpanda b...
News, Short Squeeze, Breakout and More Instantly...
2024-07-17 13:21:54 ET Shares of Swiss pharmaceuticals company Roche Holding (OTC: RHHBY) soared 7% through 11:55 a.m. ET Wednesday on positive data from phase 1 clinical trials of its new weight loss drug CT-996. But good news for Roche is bad news for the companies that no...
2024-07-14 05:20:00 ET Two pharma juggernauts, Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) , are picking up speed in their preparations for an epic battle to control the market for weight loss drugs. The prize for the victor will be a larger market share of what may b...
2024-07-13 17:52:00 ET Novo Nordisk (NYSE: NVO) is already a stock that's easy to justify buying. Between the incredible success of Ozempic, tons of demand for its weight loss medicine, and big investments in manufacturing as well as its pipeline, optimism about its future is practi...